Conference Coverage

Study finds AD accounts for hundreds of thousands of annual ED visits


 

REPORTING FROM AAD 18


Indeed, he noted, “previous U.S. population–based studies showed that people with AD have higher odds of [ED] utilization than the rest of the population.”

He and Ms. Kwa examined 2006-2012 data from the Nationwide Emergency Department Sample, which includes information on about 20% of all emergency visits in the United States.

During that period, there were 1.86 million ED visits with a primary diagnosis of AD. The annual weighted prevalence of primary diagnoses of AD stayed fairly stable through the period, ranging from 2,589 to 2,769 per 1 million visits. However, the weighted prevalence of secondary AD diagnoses grew steadily from 1,227 per 1 million visits in 2006 to 1,533 per 1 million visits in 2012.

The researchers estimated that the total cost of annual costs of AD-related ED visits grew from $86.9 million in 2006 to $172.8 million in 2012 (P less than .05).

Recommended Reading

Adverse effects low in long-term crisaborole eczema study
MDedge Internal Medicine
International survey sheds new light on adult atopic dermatitis
MDedge Internal Medicine
JAK inhibitors for atopic dermatitis might hit JAK-pot
MDedge Internal Medicine
Systemic corticosteroids not recommended for long-term treatment of eczema
MDedge Internal Medicine
Antihistamines still are prescribed inappropriately for atopic dermatitis
MDedge Internal Medicine
VIDEO: Dupilumab or cyclosporine for treating atopic dermatitis?
MDedge Internal Medicine
Upadacitinib calms itch, clears skin in moderate to severe atopic dermatitis
MDedge Internal Medicine
Anti–IL-33 antibody stakes a first-in-class claim on moderate to severe atopic dermatitis
MDedge Internal Medicine
VIDEO: With new therapies available, it’s the ‘decade of eczema,’ researcher says
MDedge Internal Medicine
Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis
MDedge Internal Medicine